Effective administration is an essential aspect of every data management platform. Join Logan Smith as he takes questions, walks through everyday use cases, and gives practical tips in administering the core capabilities of the Egnyte for Life Sciences platform.
Ask the Experts. Join an informal live chat hosted by Egnyte's Product Team as they answer any questions you have on the new eTMF solution, existing features and functionality, and future roadmap.
Successful emerging life sciences companies have an early understanding of compliance guidelines, including when to implement GLP, GMP, and GCP workflows, technologies and best practices. Marching too fast can be costly and slow down development; going too slow can result in additional regulatory scrutiny and delays. David Grote, Head of Quality at Immunocore outlines how to identify when to apply compliance principles in the drug development journey, and how to implement GxP guidances, workflows, helpful technologies, and best practices.
With sensitive company data and even more sensitive patient data, life sciences firms are at constant risk of a data breach. Whether the incident is caused by a malicious actor or results from a simple mistake, protecting data needs to be top of mind for every company. Join Robert Kuhn, Director of IT Infrastructure & Security at Travere Therapeutics, and Neil Jones, Cybersecurity Evangelist at Egnyte, as they examine the most pressing cybersecurity threats and outline practical steps to protect your organization.
The data challenges facing nimble biotechs can’t just be solved with more headcount and employing the latest technology. Cutting-edge strategies and tried and true tactics are needed to create modern data infrastructures that can glean insight out of chaos. Join Scott Sacane, Founder and CEO of Catalytic Data Science as he reviews the challenges of modern data management and how we can build processes that are scalable, secure, and compliant.
The ability to take a promising idea to build phase is a long and winding path. Building an operational framework that is scalable and flexible enough for modern biotechs is what allows for hypergrowth. Join this panel of top-tier VCs as they provide insight, trends, and lessons learned for launching successful early-stage companies.
The use of AI in drug discovery has yielded interesting candidates and new ways of "in silico" testing. Join industry expert Brandon Allgood, Chief AI Officer at Valo Health, in a discussion of how innovative biotechs are using AI as a competitive advantage in drug discovery and clinical trials.